Adams spent over 30 years in senior management positions with major
pharmaceutical companies, including Novartis Pharmaceuticals, SmithKline
Beecham and ICI Pharmaceuticals (Astra Zeneca).

deficiency pituitary

Live Webcast on Tuesday, May 3, 2005

SAN DIEGO, Neurocrine Biosciences,
Inc.

is a product-based biopharmaceutical company
focused on neurological and endocrine diseases and disorders . Adams' direction, Kos has
become fully profitable through internal strategic growth as well as through
product acquisitions and in-licensing arrangements.

known date

Viewers are encouraged to visit the website approximately 5 minutes prior to
the presentation to download or install any necessary software.

A replay of the webcast will be available approximately one hour after the
presentation concludes and will be archived until Tuesday, May 17, 2005.S.

accounts disorders

syndrome date

treatments accounts

Under Mr. Prior to joining Kos,
Mr.

groups endocrine

com

com

adrenal diseases

If you are unable to attend the webcast and would like further information
on this announcement please contact the Investor Relations Department at
Neurocrine Biosciences at (858) 617-7600 and ask for Claudia Jones or
Elizabeth Foster. Adams is President and CEO
of Kos Pharmaceuticals, Inc.

polycystic disorders

Immediately following the initial presentation, a second session will take
place at 3:10PM EST and will provide members of the financial community and
other interested investors an opportunity for an interactive question and
answer period.
Neurocrine Biosciences , Inc.

pituitary diabetes

Our product
candidates address some of the largest pharmaceutical markets in the world
including insomnia, anxiety, depression, diabetes, multiple sclerosis,
irritable bowel syndrome, eating disorders , pain, and autoimmunity.
(Nasdaq: NBIX) announced today that the Company has appointed Adrian Adams to
its Board of Directors effective immediately."

Kos, one of the fastest growing pharmaceutical companies in the U. news releases are available through the Company's
website via the Internet at http://www.neurocrine.

gonads accounts

Lyons, President and Chief Executive Officer of Neurocrine
Biosciences.

diabetes endocrine

neurocrine .

deficiency ovarian

The live presentation will take place at 8:30am Eastern Daylight Time
(EDT) / 5:30am Pacific Daylight Time (PDT) and will include indiplon marketing
highlights and an update on the Company's broad development pipeline and
research programs.com.com

adrenal date

neurocrine.neurocrine. news releases are available through the Company's
website via the Internet at http://www.

groups ovarian

com. Our product
candidates address some of the largest pharmaceutical markets in the world
including insomnia, anxiety, depression , diabetes, multiple sclerosis,
irritable bowel syndrome, eating disorders, pain, and autoimmunity .

hypogonadism conditions

Neurocrine Biosciences to Present at the 30th Annual Deutsche Bank Healthcare Conference

The presentation will be webcast and can be accessed on
the Company's website at http://www.

Neurocrine Biosciences, Inc.

gonads deficiency

The initial presentation will take place at 2:20PM Eastern Standard Time
(EST) / 11:20AM Pacific Standard Time (PST) and will include an overview of
the Company as well as an update on the Company's broad development pipeline
and research programs.
Neurocrine Biosciences , Inc. "His strategic vision and proven track record in managing
pharmaceutical development as well as sales and earnings growth will be a
valuable resource for Neurocrine.

parathyroid gonads

, (Nasdaq: NBIX) a biopharmaceutical company focused on neurological and
endocrine diseases and disorders announced today that Gary Lyons , President
and CEO will present at the 30th Annual Deutsche Bank Healthcare Conference at
the Hyatt Regency Hotel in Baltimore, Maryland, on Tuesday, May 3, 2005. Our product
candidates address some of the largest pharmaceutical markets in the world
including insomnia, anxiety, depression, diabetes, multiple sclerosis,
irritable bowel syndrome, eating disorders, pain, and autoimmunity .

thyroid date

Neurocrine Biosciences to Present at the 25th Annual SG Cowen + Company Healthcare Conference

Support groups for people with endocrine disorders - adrenal, gonads, pancreas, parathyroid, pituitary, and thyroid.

accounts help

Neurocrine Biosciences, Inc.
Viewers are encouraged to visit the website approximately 5 minutes prior to
the presentation to download or install any necessary software.

groups adrenal

Mr.

treatments diseases

Live Webcast on Wednesday, March 16, 2005

SAN DIEGO, Neurocrine Biosciences,
Inc . This presentation will be webcast and can be accessed
on the Company's website at http://www.
A replay of the webcast will be available approximately one hour after the
presentation concludes and will be archived until Wednesday, March 30, 2005.neurocrine. is a product-based biopharmaceutical company
focused on neurological and endocrine diseases and disorders.
Neurocrine Biosciences, Inc.

disorders gonads

news releases are available through the Company's
website via the Internet at http://www. SAN DIEGO, Neurocrine Biosciences, Inc.

testosterone treatments

If you are unable to attend the webcast and would like further information
on this announcement please contact the Investor Relations Department at
Neurocrine Biosciences at (858) 617-7600 and ask for Claudia Jones or
Elizabeth Foster. is a product-based biopharmaceutical company
focused on neurological and endocrine diseases and disorders.

Neurocrine Biosciences , Inc. (Nasdaq: KOSP).
"Adrian's extensive experience in launching major pharmaceutical global
brands and developing products in many therapeutic areas will be of great
benefit to Neurocrine as we embark on our commercialization program," said
Gary A.,
reported sales of $90 million in 2001 and is expected to report sales of
approximately $735 million in 2005.

treatments diseases

, (Nasdaq: NBIX) a biopharmaceutical company focused on neurological and
endocrine diseases and disorders announced today that Gary Lyons , President
and CEO will present at the 25th Annual SG Cowen Healthcare Conference at the
Boston Marriott Copley Place Hotel, Wednesday afternoon, March 16, 2005.

Neurocrine Biosciences Announces the Appointment of Adrian Adams to the Board of Directors

endocrine read

---

- - kjjkjk

Loading...

(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)